FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034269429> ?p ?o ?g. }

• W2034269429 endingPage "664" @default.
• W2034269429 startingPage "657" @default.
• W2034269429 abstract "The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study previously showed that treatment with telmisartan, an angiotensin II receptor blocker, effectively reduced the transition from incipient to overt nephropathy in Japanese type 2 diabetic patients. However, that large study included both normotensive and hypertensive patients. In the present post hoc analysis, we aimed to assess whether or not telmisartan elicits beneficial effects on the progression of microalbuminuria in normotensive patients. We randomized 163 microalbuminuric (urinary albumin-to-creatinine ratio: UACR of 100 to 300 mg/g creatinine) normotensive type 2 diabetic patients to treatment with telmisartan (40 or 80 mg once daily) or placebo over 52 weeks. The patients treated with either dose of telmisartan showed lower transition rates from microalbuminuria to overt nephropathy compared to the placebo group. In addition, more patients on telmisartan reverted to normoalbuminuria (UACR<30 mg/g creatinine): 15.5% of the 40 mg group, 19.6% of the 80 mg group, and 1.9% of the placebo group. In normotensive patients treated with telmisartan, changes in UACR were not significantly correlated with changes in blood pressure. Side effects did not differ among the groups. The present study demonstrates that telmisartan prevents the progression of microalbuminuria (in some cases induces remission of albuminuria) in normotensive Japanese patients with type 2 diabetes. Telmisartan is shown to be safe and well tolerated in these patients." @default.
• W2034269429 created "2016-06-24" @default.
• W2034269429 creator A5003552916 @default.
• W2034269429 creator A5004116787 @default.
• W2034269429 creator A5006861620 @default.
• W2034269429 creator A5027143314 @default.
• W2034269429 creator A5032317621 @default.
• W2034269429 creator A5039655833 @default.
• W2034269429 creator A5045008956 @default.
• W2034269429 creator A5076136934 @default.
• W2034269429 creator A5077370623 @default.
• W2034269429 date "2008-04-01" @default.
• W2034269429 modified "2023-10-16" @default.
• W2034269429 title "Microalbuminuria Reduction with Telmisartan in Normotensive and Hypertensive Japanese Patients with Type 2 Diabetes: A Post-Hoc Analysis of the Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study" @default.
• W2034269429 cites W1984061204 @default.
• W2034269429 cites W1997932141 @default.
• W2034269429 cites W2000154505 @default.
• W2034269429 cites W2001933911 @default.
• W2034269429 cites W2017192955 @default.
• W2034269429 cites W2022854575 @default.
• W2034269429 cites W2027997261 @default.
• W2034269429 cites W2045045479 @default.
• W2034269429 cites W2052653818 @default.
• W2034269429 cites W2059792416 @default.
• W2034269429 cites W2059911502 @default.
• W2034269429 cites W2075093222 @default.
• W2034269429 cites W2084048646 @default.
• W2034269429 cites W2096875294 @default.
• W2034269429 cites W2097288698 @default.
• W2034269429 cites W2118286022 @default.
• W2034269429 cites W2125357334 @default.
• W2034269429 cites W2128978422 @default.
• W2034269429 cites W2132766113 @default.
• W2034269429 cites W2139968474 @default.
• W2034269429 cites W2140563977 @default.
• W2034269429 cites W2156121263 @default.
• W2034269429 cites W2161474086 @default.
• W2034269429 cites W2170483116 @default.
• W2034269429 cites W2292780392 @default.
• W2034269429 cites W3021250193 @default.
• W2034269429 cites W4256636055 @default.
• W2034269429 doi "https://doi.org/10.1291/hypres.31.657" @default.
• W2034269429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18633177" @default.
• W2034269429 hasPublicationYear "2008" @default.
• W2034269429 type Work @default.
• W2034269429 sameAs 2034269429 @default.
• W2034269429 citedByCount "51" @default.
• W2034269429 countsByYear W20342694292012 @default.
• W2034269429 countsByYear W20342694292013 @default.
• W2034269429 countsByYear W20342694292014 @default.
• W2034269429 countsByYear W20342694292015 @default.
• W2034269429 countsByYear W20342694292016 @default.
• W2034269429 countsByYear W20342694292017 @default.
• W2034269429 countsByYear W20342694292018 @default.
• W2034269429 countsByYear W20342694292019 @default.
• W2034269429 countsByYear W20342694292020 @default.
• W2034269429 countsByYear W20342694292021 @default.
• W2034269429 countsByYear W20342694292022 @default.
• W2034269429 countsByYear W20342694292023 @default.
• W2034269429 crossrefType "journal-article" @default.
• W2034269429 hasAuthorship W2034269429A5003552916 @default.
• W2034269429 hasAuthorship W2034269429A5004116787 @default.
• W2034269429 hasAuthorship W2034269429A5006861620 @default.
• W2034269429 hasAuthorship W2034269429A5027143314 @default.
• W2034269429 hasAuthorship W2034269429A5032317621 @default.
• W2034269429 hasAuthorship W2034269429A5039655833 @default.
• W2034269429 hasAuthorship W2034269429A5045008956 @default.
• W2034269429 hasAuthorship W2034269429A5076136934 @default.
• W2034269429 hasAuthorship W2034269429A5077370623 @default.
• W2034269429 hasBestOaLocation W20342694291 @default.
• W2034269429 hasConcept C126322002 @default.
• W2034269429 hasConcept C126894567 @default.
• W2034269429 hasConcept C134018914 @default.
• W2034269429 hasConcept C142724271 @default.
• W2034269429 hasConcept C204787440 @default.
• W2034269429 hasConcept C27081682 @default.
• W2034269429 hasConcept C2776174234 @default.
• W2034269429 hasConcept C2777180221 @default.
• W2034269429 hasConcept C2779716603 @default.
• W2034269429 hasConcept C2779922275 @default.
• W2034269429 hasConcept C2780306776 @default.
• W2034269429 hasConcept C2781184683 @default.
• W2034269429 hasConcept C2781203188 @default.
• W2034269429 hasConcept C2910068830 @default.
• W2034269429 hasConcept C555293320 @default.
• W2034269429 hasConcept C67761136 @default.
• W2034269429 hasConcept C71924100 @default.
• W2034269429 hasConcept C84393581 @default.
• W2034269429 hasConceptScore W2034269429C126322002 @default.
• W2034269429 hasConceptScore W2034269429C126894567 @default.
• W2034269429 hasConceptScore W2034269429C134018914 @default.
• W2034269429 hasConceptScore W2034269429C142724271 @default.
• W2034269429 hasConceptScore W2034269429C204787440 @default.
• W2034269429 hasConceptScore W2034269429C27081682 @default.
• W2034269429 hasConceptScore W2034269429C2776174234 @default.
• W2034269429 hasConceptScore W2034269429C2777180221 @default.
• W2034269429 hasConceptScore W2034269429C2779716603 @default.
• W2034269429 hasConceptScore W2034269429C2779922275 @default.

• next